These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7832521)

  • 1. Development of an efficient bioprocess for poultry vaccines using high-density insect cell culture.
    Bentley WE; Wang MY; Vakharia V
    Ann N Y Acad Sci; 1994 Nov; 745(1):336-59. PubMed ID: 7832521
    [No Abstract]   [Full Text] [Related]  

  • 2. Self-assembly of the infectious bursal disease virus capsid protein, rVP2, expressed in insect cells and purification of immunogenic chimeric rVP2H particles by immobilized metal-ion affinity chromatography.
    Wang MY; Kuo YY; Lee MS; Doong SR; Ho JY; Lee LH
    Biotechnol Bioeng; 2000 Jan; 67(1):104-11. PubMed ID: 10581441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant canarypox virus expressing the VP2 protein of infectious bursal disease virus induces protection in vaccinated SPF chickens.
    Zanetti FA; Cardona R; Federico CR; Chimeno-Zoth S; Calamante G
    Virol Sin; 2016 Jun; 31(3):266-9. PubMed ID: 27007879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient expression of VP2 in Nicotiana benthamiana and its use as a plant-based vaccine against infectious bursal disease virus.
    Gómez E; Lucero MS; Chimeno Zoth S; Carballeda JM; Gravisaco MJ; Berinstein A
    Vaccine; 2013 May; 31(23):2623-7. PubMed ID: 23583894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination with E. coli recombinant empty viral particles of infectious bursal disease virus (IBDV) confer protection.
    Rogel A; Benvenisti L; Sela I; Edelbaum O; Tanne E; Shachar Y; Zanberg Y; Gontmakher T; Khayat E; Stram Y
    Virus Genes; 2003 Oct; 27(2):169-75. PubMed ID: 14501195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of infectious bursal disease virus antigen VP2 for cell surface location fails to enhance immunogenicity.
    Heine HG; Hyatt AD; Boyle DB
    Virus Res; 1994 Jun; 32(3):313-28. PubMed ID: 8079513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of two recombinant HVT-IBD vaccines by VP2 insert detection and cell-mediated immunity after vaccination of specific pathogen-free chickens.
    Ingrao F; Rauw F; van den Berg T; Lambrecht B
    Avian Pathol; 2017 Jun; 46(3):289-299. PubMed ID: 27897452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralizing-antibody-mediated protection of chickens against infectious bursal disease via one-time vaccination with inactivated recombinant Lactococcus lactis expressing a fusion protein constructed from the RCK protein of Salmonella enterica and VP2 of infectious bursal disease virus.
    Wang W; Song Y; Liu L; Zhang Y; Wang T; Zhang W; Li K; Qi X; Gao Y; Gao L; Liu C; Zhang Y; Wang Y; Pan Q; He G; Wang X; Cui H
    Microb Cell Fact; 2019 Jan; 18(1):21. PubMed ID: 30704494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete, long-lasting protection against lethal infectious bursal disease virus challenge by a single vaccination with an avian herpesvirus vector expressing VP2 antigens.
    Tsukamoto K; Saito S; Saeki S; Sato T; Tanimura N; Isobe T; Mase M; Imada T; Yuasa N; Yamaguchi S
    J Virol; 2002 Jun; 76(11):5637-45. PubMed ID: 11991992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of VP2 protein expressed in E. coli for protection against highly virulent infectious bursal disease virus.
    Omar AR; Kim CL; Bejo MH; Ideris A
    J Vet Sci; 2006 Sep; 7(3):241-7. PubMed ID: 16871018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of two strains of Marek's disease virus serotype 1 for the development of recombinant vaccines against very virulent infectious bursal disease virus.
    Li K; Liu Y; Liu C; Gao L; Gao Y; Zhang Y; Cui H; Qi X; Zhong L; Wang X
    Antiviral Res; 2017 Mar; 139():153-160. PubMed ID: 27908832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active and passive protection against variant and classic infectious bursal disease virus strains induced by baculovirus-expressed structural proteins.
    Vakharia VN; Snyder DB; Lütticken D; Mengel-Whereat SA; Savage PK; Edwards GH; Goodwin MA
    Vaccine; 1994 Apr; 12(5):452-6. PubMed ID: 8023554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active cross-protection induced by a recombinant baculovirus expressing chimeric infectious bursal disease virus structural proteins.
    Snyder DB; Vakharia VN; Mengel-Whereat SA; Edwards GH; Savage PK; Lütticken D; Goodwin MA
    Avian Dis; 1994; 38(4):701-7. PubMed ID: 7702501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infectious bursal disease subunit vaccination.
    Villegas P; Hamoud M; Purvis LB; Perozo F
    Avian Dis; 2008 Dec; 52(4):670-4. PubMed ID: 19166061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of recombinant VP2 vaccine for the prevention of infectious bursal disease of chickens.
    Rong J; Cheng T; Liu X; Jiang T; Gu H; Zou G
    Vaccine; 2005 Sep; 23(40):4844-51. PubMed ID: 15979770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fowl adenovirus recombinant expressing VP2 of infectious bursal disease virus induces protective immunity against bursal disease.
    Sheppard M; Werner W; Tsatas E; McCoy R; Prowse S; Johnson M
    Arch Virol; 1998; 143(5):915-30. PubMed ID: 9645198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against infectious bursal disease virulent challenge conferred by a recombinant avian adeno-associated virus vaccine.
    Perozo F; Villegas P; Estevez C; Alvarado IR; Purvis LB; Williams S
    Avian Dis; 2008 Jun; 52(2):315-9. PubMed ID: 18646463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and large-scale use of recombinant VP2 vaccine for the prevention of infectious bursal disease of chickens.
    Pitcovski J; Gutter B; Gallili G; Goldway M; Perelman B; Gross G; Krispel S; Barbakov M; Michael A
    Vaccine; 2003 Dec; 21(32):4736-43. PubMed ID: 14585684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large-scale manufacture and use of recombinant VP2 vaccine against infectious bursal disease in chickens.
    Rong J; Jiang T; Cheng T; Shen M; Du Y; Li S; Wang S; Xu B; Fan G
    Vaccine; 2007 Nov; 25(46):7900-8. PubMed ID: 17923174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective immune responses of recombinant VP2 subunit antigen of infectious bursal disease virus in chickens.
    Pradhan SN; Prince PR; Madhumathi J; Roy P; Narayanan RB; Antony U
    Vet Immunol Immunopathol; 2012 Aug; 148(3-4):293-301. PubMed ID: 22795186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.